Haploinsufficiency of Apc leads to ineffective hematopoiesis.
about
Engineering mouse models with myelodysplastic syndrome human candidate genes; how relevant are they?Knockdown of Hspa9, a del(5q31.2) gene, results in a decrease in hematopoietic progenitors in miceTgif1 regulates quiescence and self-renewal of hematopoietic stem cellsGlobal transcriptome analyses of human and murine terminal erythroid differentiation.Role of casein kinase 1A1 in the biology and targeted therapy of del(5q) MDS.Genetic pathways leading to therapy-related myeloid neoplasms.Allelic methylation levels of the noncoding VTRNA2-1 located on chromosome 5q31.1 predict outcome in AMLKnockdown of HSPA9 induces TP53-dependent apoptosis in human hematopoietic progenitor cells.Microwaving blood as a non-destructive technique for haemoglobin measurements on microlitre samples.Apc regulates the function of hematopoietic stem cells largely through β-catenin-dependent mechanisms.Cell intrinsic and extrinsic factors synergize in mice with haploinsufficiency for Tp53, and two human del(5q) genes, Egr1 and Apc.Lack of interferon-γ receptor results in a microenvironment favorable for intestinal tumorigenesis.Haploinsufficiency of del(5q) genes, Egr1 and Apc, cooperate with Tp53 loss to induce acute myeloid leukemia in mice.Unraveling the molecular pathophysiology of myelodysplastic syndromes.Molecular dissection of the 5q deletion in myelodysplastic syndrome.Lenalidomide as a disease-modifying agent in patients with del(5q) myelodysplastic syndromes: linking mechanism of action to clinical outcomesSecondary Adult Acute Myeloid Leukemia: a Review of Our Evolving Understanding of a Complex Disease Process.Therapy-related myeloid neoplasms: when genetics and environment collide.β-Catenin Is a Candidate Therapeutic Target for Myeloid Neoplasms with del(5q).Wnt Signaling in Normal and Malignant Stem Cells.Cooperative loss of RAS feedback regulation drives myeloid leukemogenesis.Hematopoietic stem cell development requires transient Wnt/β-catenin activity.Clonal evolution in myelodysplastic syndromes with isolated del(5q): the importance of genetic monitoring.Downregulation but lack of promoter hypermethylation or somatic mutations of the potential tumor suppressor CXXC5 in MDS and AML with deletion 5q.Inhibition of WNT signaling in the bone marrow niche prevents the development of MDS in the Apcdel/+ MDS mouse model.Isolated del(5q) in Patients Following Therapies for Various Malignancies May Not All Be Clinically Significant.
P2860
Q26828777-AF9BFADF-07FF-49B5-985F-4B534B2EA88EQ28114815-B133735E-5CF1-434C-B153-636F3577CDE8Q30412861-F34D2273-31B7-49C8-B410-0A4999548C49Q33697238-526D41E7-E6A3-4EF3-84B9-D55121407A7AQ34348631-A6E1E12F-104F-49DC-B6A5-2C572EB45404Q35039992-E6451CA3-0361-478D-AEFB-F7D7C7C760BFQ35651714-A5466E76-0F2E-43A8-AC1F-8B96A497CD0FQ36274044-2A884062-9E07-47F7-8124-12A547814BF5Q36843358-58422634-77CF-4FAB-99FC-68278DA855DFQ36850827-4C35FDE2-3039-4621-BD84-DE502A56B30EQ37464115-16817093-4ED0-4C81-8DAB-B22A7C73BBF0Q37520458-48E494D0-DD0F-4A64-9C08-AFA0C2F0EA9BQ37585218-806DB546-CE4B-4CF8-A539-17197A00CC24Q37671806-566C610E-62C1-4D11-84FB-D8AF799E7DA3Q37937810-10E0CD48-3170-4269-8AD4-02600D9B7991Q38135713-BEFFC060-2F1B-41B0-A29A-88A7CFE2E005Q38542828-923CD2D1-8E52-4E75-BBEB-5D653C9E209BQ38611096-674C0BC9-C7EE-4888-B9A3-40A413F008C3Q38727081-33EE5BED-835A-46F5-BE4B-174D1ED835BFQ39306017-15617202-821B-4645-86DF-2C3049E10183Q40094852-45B05C86-A092-4C8F-9027-B26FBDBF44F6Q41814485-7E77E586-E273-4530-903C-3646416E98CBQ42586752-F6C24052-48A2-4074-B4D5-C20373E8B309Q46402216-89988F71-8F2A-407C-A555-77B71232F4E8Q48355552-AF3DA440-6C94-40E8-8ABC-5F028A3ECE8EQ53469467-F40CFCF0-A6F3-4905-9F52-10777B92DA57
P2860
Haploinsufficiency of Apc leads to ineffective hematopoiesis.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh
2010年學術文章
@zh-hant
name
Haploinsufficiency of Apc leads to ineffective hematopoiesis.
@en
Haploinsufficiency of Apc leads to ineffective hematopoiesis.
@nl
type
label
Haploinsufficiency of Apc leads to ineffective hematopoiesis.
@en
Haploinsufficiency of Apc leads to ineffective hematopoiesis.
@nl
prefLabel
Haploinsufficiency of Apc leads to ineffective hematopoiesis.
@en
Haploinsufficiency of Apc leads to ineffective hematopoiesis.
@nl
P2093
P2860
P1433
P1476
Haploinsufficiency of Apc leads to ineffective hematopoiesis.
@en
P2093
Anthony A Fernald
Jianghong Wang
John Anastasi
Michelle M Le Beau
Zhijian Qian
P2860
P304
P356
10.1182/BLOOD-2009-11-251835
P407
P577
2010-01-11T00:00:00Z